Suchergebnisse - "Guan, Xiuwen"

PubPharm (11)

1

Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer : a multicenter prospective observational study

enthalten in: Chinese medical journal | 2023

von Wang, J. | Liu, Y. | Zhang, R. | +7

2

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients

enthalten in: Cancer medicine | 2022

von Liu, B. | Yi, Z. | Guan, Y. | +10

3

Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer : A study of the National Cancer Center, China

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Li, Y. | Mo, H. | Guan, X. | +14

4

Antibody-drug conjugates in HER2-positive breast cancer

enthalten in: Chinese medical journal | 2021

von Li, L. | Zhang, D. | Liu, B. | +5

5

Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China

enthalten in: Breast (Edinburgh, Scotland) | 2021

von Li, Y. | Li, Q. | Mo, H. | +16

6

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

enthalten in: International journal of cancer | 2020

von Ma, F. | Guan, Y. | Yi, Z. | +16

ErratumIn: Int J Cancer. 2020 Jun 15;146(12):E8. - PMID 32320496

7

Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Guan, X. | Liu, B. | Niu, Y. | +9

8

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients : A Phase I Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Li, Q. | Guan, X. | Chen, S. | +16

9

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Guan, X. | Ma, F. | Li, C. | +13

10

Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition : a proof-of-principle study on the heterogeneity of circulating tumor cells

enthalten in: Oncotarget | 2016

von Guan, X. | Ma, F. | Liu, S. | +7